| Authors: |
Nabel CS; Mass General Brigham Cancer Institute, Boston, Massachusetts.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Sussman CB; Harvard Medical School, Boston, Massachusetts.; University of Maryland Medical Center, Baltimore, Maryland., Whittaker CA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Butty VL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Peterson JL; Mass General Brigham Cancer Institute, Boston, Massachusetts., Martin HK; Department of Pathology, Massachusetts General Brigham, Boston, Massachusetts., Louissaint A Jr; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Brigham, Boston, Massachusetts., Bru-Tari E; University of Geneva, Geneva, Switzerland., Chera S; University of Geneva, Geneva, Switzerland., Ligon AH; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Division of Clinical Cytogenetics, Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Boston, Massachusetts., Yeap BY; Mass General Brigham Cancer Institute, Boston, Massachusetts., Herrera PL; University of Geneva, Geneva, Switzerland., Hung YP; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Brigham, Boston, Massachusetts. |
